2 questions: How did BLA come on the radar of Glaucus, for it to publish its report? Did Glaucus's short selling syndicate have a heads up on the report before it was 'published'?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
I88 History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
BM8 Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential